Cooper Companies Inc

COO

Equity

ISIN US2166485019 / Valor 132951296

NASDAQ (2025-04-07)

USD 73.31-0.62%

Cooper Companies Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Cooper Companies Inc. is a prominent global medical device company that specializes in providing a range of products and services aimed at enhancing healthcare outcomes. The company operates through two main business units: CooperVision and CooperSurgical. CooperVision is a leading manufacturer of contact lenses, offering a wide array of products that cater to various vision correction needs, including myopia, hyperopia, astigmatism, and presbyopia. CooperSurgical focuses on women's health, providing medical devices and fertility solutions that support healthcare professionals in delivering effective patient care. Through a commitment to innovation and strategic investments, Cooper Companies aims to address current healthcare demands while positioning itself for future growth opportunities.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

In the third quarter of 2024, Cooper Companies Inc. reported a revenue increase of 8% year-over-year, reaching $1,002.8 million. This growth was driven by a 7% increase in CooperVision (CVI) revenue to $675.6 million and a 9% increase in CooperSurgical (CSI) revenue to $327.2 million.

Earnings Per Share

Cooper Companies Inc. achieved a GAAP diluted earnings per share (EPS) of $0.52 for the third quarter of 2024, marking a 22% increase from the previous year's third quarter. On a non-GAAP basis, the diluted EPS was $0.96, reflecting a 14% rise from the same period last year.

Operating Margins

The company's operating margin for the third quarter of 2024 improved to 19% from 16% in the previous year's third quarter. On a non-GAAP basis, the operating margin was 26%, up from 24% last year, supported by strong gross margins and SG&A expense leverage.

Free Cash Flow

Cooper Companies Inc. generated $207.5 million in cash from operations during the third quarter of 2024. After accounting for capital expenditures of $89.0 million, the company reported a free cash flow of $118.5 million for the quarter.

Financial Outlook

For fiscal year 2024, Cooper Companies Inc. raised its financial guidance, projecting total revenue between $3,892 million and $3,913 million, with organic growth of 8% to 8.5%. The company also anticipates a non-GAAP diluted EPS of $3.64 to $3.67 for the fiscal year.

Summarized from source with an LLMView Source

Key figures

-25.6%1Y

%3Y

%5Y

Performance

26.2%1Y

26.5%3Y

26.5%5Y

Volatility